Expert Opinion on Emerging Drugs
 | |
Abbreviated title (ISO 4) | Exp. Opin. Emerg. Drugs |
|---|---|
| Discipline | Pharmacology |
| Language | English |
| Edited by | Claire Attwood |
| Publication details | |
| Publisher | |
| Frequency | Quarterly |
| 3.058 | |
| Indexing | |
| ISSN |
1744-7623 |
| Links | |
Expert Opinion on Emerging Drugs is a quarterly peer-reviewed medical journal publishing structured reviews on drugs/drug classes emerging onto the market across all therapy areas. Each review includes an "expert opinion" section, in which authors are asked to provide their personal view on the current status and future direction of the research discussed. It is published by Informa. According to the Journal Citation Reports, the journal has a 2014 impact factor of 3.058.[1]
References
- ↑ "Expert Opinion on Emerging Drugs". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.
External links
This article is issued from Wikipedia - version of the Sunday, August 02, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.